Association of Time to PSA Nadir and Logarithm of PSA Velocity After Progression in Metastatic Prostate Cancer with Prior Primary Androgen Deprivation Therapy

SamsonYS Chan; PeterKF Chiu; Kwan-Lun Ho; SimonSM HOU; Chi-Fai NG; JeremyYC Teoh; JamesHL Tsu; SteffiKK Yuen; Ka-Wing Wong; Ming-Kwong Yiu

doi:10.4103/1008-682x.164921

Association of Time to PSA Nadir and Logarithm of PSA Velocity After Progression in Metastatic Prostate Cancer with Prior Primary Androgen Deprivation Therapy

Asian Journal of Andrology ◽

10.4103/1008-682x.164921 ◽

2015 ◽

Vol 0 (0) ◽

pp. 0

Author(s):

SamsonYS Chan ◽

PeterKF Chiu ◽

Kwan-Lun Ho ◽

SimonSM HOU ◽

Chi-Fai NG ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Androgen Deprivation ◽

Primary Androgen Deprivation Therapy ◽

Psa Velocity ◽

Psa Nadir ◽

Primary Androgen Deprivation

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12313 ◽

2014 ◽

Vol 13 (2) ◽

pp. e65-e71 ◽

Cited By ~ 2

Author(s):

Jeremy Yuen Chun Teoh ◽

James Hok Leung Tsu ◽

Steffi Kar Kei Yuen ◽

Samson Yun Sang Chan ◽

Peter Ka Fung Chiu ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Specific Antigen ◽

Androgen Deprivation ◽

Survival Outcomes ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer

Asian Journal of Andrology ◽

10.4103/aja.aja_9_19 ◽

2019 ◽

Vol 21 (6) ◽

pp. 635

Author(s):

Akihiro Yano ◽

Makoto Kagawa ◽

Hideki Takeshita ◽

Yohei Okada ◽

Makoto Morozumi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Dehydroepiandrosterone Sulfate ◽

Androgen Deprivation ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer

World Journal of Urology ◽

10.1007/s00345-015-1621-5 ◽

2015 ◽

Vol 34 (3) ◽

pp. 319-327 ◽

Cited By ~ 5

Author(s):

Yasuhide Kitagawa ◽

Satoru Ueno ◽

Kouji Izumi ◽

Yoshifumi Kadono ◽

Atsushi Mizokami ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Clinical Outcomes ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Specific Antigen ◽

Androgen Deprivation ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

Missense polymorphism in HSD3B1 in Japanese men treated with primary androgen-deprivation therapy for metastatic prostate cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e17051 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e17051-e17051

Author(s):

Masaki Shiota ◽

Naohiro Fujimoto ◽

Kenjiro Imada ◽

Eiji Kashiwagi ◽

Ario Takeuchi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Androgen Deprivation ◽

Japanese Men ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

MP07-13 BASELINE SERUM DEHYDROEPIANDROSTERONE SULFATE (DHEAS) CAN PREDICT RESPONSIVENESS TO PRIMARY ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH HORMONE NAÏVE METASTATIC PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.2216 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Akihiro Yano ◽

Hironori Sugiyama ◽

Eiken Cho ◽

Hideki Takeshita ◽

Yohei Okada ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Dehydroepiandrosterone Sulfate ◽

Androgen Deprivation ◽

Baseline Serum ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis

Prostate Cancer and Prostatic Diseases ◽

10.1038/pcan.2011.14 ◽

2011 ◽

Vol 14 (3) ◽

pp. 248-252 ◽

Cited By ~ 38

Author(s):

T Sasaki ◽

T Onishi ◽

A Hoshina

Keyword(s):

Prostate Cancer ◽

Bone Metastasis ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Primary Androgen Deprivation Therapy ◽

Psa Nadir ◽

Primary Androgen Deprivation ◽

Nadir Psa Level ◽

Survival Predictors

Cessation of Primary Androgen Deprivation Therapy for Men With Localized Prostate Cancer

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2015.02.013 ◽

2015 ◽

Vol 13 (4) ◽

pp. 359-363 ◽

Cited By ~ 3

Author(s):

Naohiro Fujimoto ◽

Tatsuhiko Kubo ◽

Ikko Tomisaki

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

724 TRANS-PACIFIC VARIATION IN OUTCOMES FOR MEN TREATED WITH PRIMARY ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2013.02.283 ◽

2013 ◽

Vol 189 (4S) ◽

Cited By ~ 1

Author(s):

Matthew Cooperberg ◽

Shiro Hinotsu ◽

Mikio Namiki ◽

Peter Carroll ◽

Hideyuki Akaza

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

231: Predicting Overall Survival among Prostate Cancer Patients Treated with Primary Androgen Deprivation Therapy Versus Expectant Management

The Journal of Urology ◽

10.1016/s0022-5347(18)30496-8 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 77-77

Author(s):

Jennifer Cullen ◽

Yongmei Chen ◽

Jinxiu Zhao ◽

David G. McLeod ◽

Grace L. Lu-Yao

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Expectant Management ◽

Androgen Deprivation ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapy

The Prostate ◽

10.1002/pros.23026 ◽

2015 ◽

Vol 75 (14) ◽

pp. 1499-1509 ◽

Cited By ~ 10

Author(s):

Kasper D. Berg ◽

Martin A. Røder ◽

Frederik B. Thomsen ◽

Ben Vainer ◽

Thomas A. Gerds ◽

...

Keyword(s):

Prostate Cancer ◽

Protein Expression ◽

Androgen Deprivation Therapy ◽

Predictive Value ◽

Advanced Prostate Cancer ◽

Androgen Deprivation ◽

Castration Resistant Prostate Cancer ◽

Primary Androgen Deprivation Therapy ◽

Castration Resistant ◽

Primary Androgen Deprivation